Primary Menu

Skip to content
Lycera
  • About Us
    • Corporate Overview
    • Management Team
    • Board of Directors
    • Scientific Advisory Board
    • Expanded Access
  • Scientific Approach
    • Scientific Approach
    • Immune Suppression
      • LYC-30937-EC
    • Immune Activation
      • LYC-55716
      • New IO Targets
  • Pipeline
  • Collaboration
  • Investors
    • Investors
    • Investor FAQ’s
    • Contact Us
  • News & Events
    • Press Releases
    • Lycera in the News
  • Careers
    • Contact Us

Merck ups autoimmune prize to $600M for small Michigan biotech

  Mar 7, 2013    FierceBiotech

Footer Menu

  • Contact Us

Social Media Menu

  • LinkedIn
© 2018 Lycera - website by Kinetic Studios